Skip to content

rTMS Brain Stimulation vs Cariprazine for Treating Negative Symptoms of Schizophrenia

Study of Efficacy of High Frequency Rtms Versus Cariprazine in the Management of Negative Symptoms in Patients With Schizophrenia : A Randomized Control Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105250
Enrollment
48
Registered
2026-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F200- Paranoid schizophrenia

Interventions

Intervention1: repetitive transcranial magnetic stimulation: 10 sessions of rtms (high frequency-10 hertz) will be given for 10 consecutive days at left dlpcf(left side of head). Each rtms session is

Sponsors

Dr MD Faisal Anjum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of schizophrenia as per ICD-11 Duration of disorder more than 6 months Stable antipsychotic dose more than equal to 1 month Written informed consent

Exclusion criteria

Exclusion criteria: Significant unstable medical condition like uncontrolled hypertension complicated diabetes mellitus History of unprovoked seizures intracranial neoplasms or intracranial surgery or history of severe head injury or cerebrovascular disease Any metallic medical devices such as chips pumps pacemakers cochlear implants dental implants permanent piercings and tattoos containing ferromagnetic ink if the coil position is less than 10 cm away Prior neuromodulation within the last 6 months Active substance use disorder except caffeine and tobacco

Design outcomes

Primary

MeasureTime frame
To assess the reduction in negative symptoms after 2 weeks of high frequency rTMS versus Cariprazine treatmentTimepoint: It will be assessed at baseline, week 2, week 4 and at week 12

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr MD Faisal Anjum

Eras lucknow medical college and hospital

kushagravarma1@gmail.com8408082333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026